Our Website: https://www.findinggeniuspodcast.com/ Subscribe and review our Podcast on iTunes: https://apple.co/2L6tN88 Follow us on: Facebook: https://web.facebook.com/futuretechpodcast/ Twitter: https://twitter.com/finding_genius Instagram: https://www.instagram.com/findinggeniuspodcas They're everywhere, even the trees. Petr Klimes researches the ecological roles of insects, especially ants in Papa New Guinea, where many species are less accessible for research. He shares interesting ant facts and tales along with questions he's pursing. Listen and learn 1. How, despite both being social insects, ants interact with their food and world in much more diverse ways than their bee cousins,  2. What interesting examples of parasitism, symbiosis, and mutualism exist in ant species, and 3. What next steps Petr Klimes plans to take by researching how ants are responding to climate change and different habitat types available. Petr Klimes is the laboratory head of the Laboratory of Ecology and Evolution of Social Insects with the University of South Bohemia Biology Centre CAS. He's interested in ants that live in tropical trees and spread across the islands in the pacific, specifically their evolution and interaction with plants and other animals. One remarkable aspect of ants' life cycles and habits is the vast diversity among different species. Unlike bees, which are exclusively pollinators, or wasps, which are predators, ant interactions vary widely. Some are predators, some are omnivores. Some ant colony structures include more than one ant queen and some don't. Some are highly specialized in food and nest choice and some are opportunistic, eating whatever and living where ever is available. Petr Klimes spent time in Papa New Guinea comparing ground and arboreal ants. Ground ants are mostly predators, but tree ants tend to work with other insects like aphids. He shares many fascinating examples of ant interactions, from parasitism to symbiotic relationships with plants or other insects like aphids. Unlike ant species in the U.S., which look fairly similar to each other, the morphology in the tropics is extreme. One species, for example, lives in leaf litter and is about 1 millimeter long, has triangle-shaped "hats" and predates with sharp mandibles, eating tiny, fast-moving insects. In Borneo, another large species lives in trees and are dimorphic, with large soldiers and small foragers. He hopes to embark on a new project soon to study species interaction and biology in terms of how climate change and forest change is influencing ant communities.  For more, see his lab's website: antscience.com. Available on Apple Podcasts: apple.co/2Os0myK #ants #insects #Findinggeniuspodcast #antkeeping #nature #bugs #Healthpodcast #InternalMedicine ... https://www.youtube.com/watch?v=lBMLssRHrZ4

Is this really the deciding factor on what medicine gets released to the public? ? In this video John Droz reveals that one of the deciding factors about what drugs get released is the political INFLUENCE of the company manufacturing it. And the more influential the company is, the higher their chance of being given the green light, even though there might be other drugs produced by other companies with less influence that can deliver better results. ? This circumstance is definitely worrisome, as the public’s interest appears to not actually be a PRIORITY. ? What are your thoughts regarding this matter? Let us know in the comments. ... https://www.youtube.com/watch?v=wBnBzQW-Orw

CHECK OUT THE COMPLETE EPISODE ? youtube.com/embed/WFReXPmvlCU?si Explore the intricate dynamics of alpha males in baboon societies and how their social hierarchy affects not only their psychological well-being but also their physiology. Join us as Robert M. Sapolsky delve into the fascinating journey of rising through the ranks, the impact of social privilege, and the contrast between male and female primates in the wild. Discover the parallels between baboon behavior and human social structures, gaining a unique perspective on the challenges and changes individuals face as they navigate the complexities of leadership. #alphamale #alphamalelifestyle #alphamalestrategies ... https://www.youtube.com/watch?v=zz6Ge2wqAvw

Our Website: https://www.findinggeniuspodcast.com/ Subscribe and review our Podcast on iTunes: https://apple.co/2L6tN88 Follow us on: Facebook: https://web.facebook.com/futuretechpodcast/ Twitter: https://twitter.com/finding_genius Instagram: https://www.instagram.com/findinggeniuspodcas A must-listen for anyone touched by thyroid cancer, this conversation offers not only accessible information, it takes an interesting turn. We learn that the endocrinologist Ruchi Gaba and Richard both have experienced papillary thyroid carcinoma diagnoses and treatment. This lends the discussion a clinical and personal perspective that makes the information delivery even more helpful. Listen and learn 1. What the basics on the different types of thyroid cancer are with corresponding treatments and survival rates, 2. How thyroid cancer rates are increasing over the past few years and speculation on why, and 3. What cutting-edge treatments are newly available such as a gene-therapy treatment that adds a year or more to an advanced thyroid cancer patient's diagnosis.  Ruchi Gaba is an assistant professor of medicine in the endocrinology division at Baylor College of Medicine in Houston, Texas. She's also the medical director for their Thyroid and Parathyroid Center, which addresses thyroid cancers and multiple endocrinal neoplasia. They're a world class medical center that develops very individualized plans for every patient; Dr. Gaba's inspiration for the center came after her own experience with a thyroid cancer diagnosis left her keenly aware of the need for specialists who know exactly what to look for. She gives listeners a stellar line up of the basics, from discussing the four types of cancer and special issues and treatments for each. "Surgery is the main modality for any type of thyroid cancer," she says. For the most common type of thyroid cancer, papillary, radioactive iodine is usually a follow up treatment, designed to kill microscopic cancer cells left behind after thyroid cancer surgery. She explains that some patients become iodine avid, which means the thyroid has less tendency to pick up the iodine. However, clinicians are now able to treat these patients with a new therapy that addresses this, enabling the thyroid to pick up the iodine again. Another "game changer" treatment she describes involves gene therapy, where they can now target cells with the particular gene mutation driving the cancer and kill those cells. She and Richard each discuss their own personal experiences and address reoccurrence rates for thyroid papillary cancer as well as its growth habit. Listen in for a meaningful conversation about this growing health concern. For more, see her web page at Baylor: bcm.edu/people-search/ruchi-gaba-21640. Available on Apple Podca ... https://www.youtube.com/watch?v=KIsCnRyXJc0